Ta. Leslie et al., ACRODERMATITIS CHRONICA ATROPHICANS - A CASE-REPORT AND REVIEW OF THELITERATURE, British journal of dermatology, 131(5), 1994, pp. 687-693
We report a 55-year-old woman with acrodermatitis chronica atrophicans
(ACA) and a peripheral sensory neuropathy. ACA is an uncommon late cu
taneous manifestation of Lyme disease, which follows disseminated Borr
elia burgdorferi infection. This is the second published case from the
U.K. since serological diagnosis has been available. In this patient
the diagnosis was confirmed by serology using a sensitive enzyme-linke
d immunosorbent assay and immunoblotting techniques. B. burgdorferi DN
A was demonstrated in the affected skin using the polymerase chain rea
ction, although staining and cultures for the organism were negative.
Recommended treatment of ACA is with oral doxycycline 100 mg twice dai
ly for 28 days, but our patient did not respond well to this regimen.
She was therefore treated with ceftriaxone intravenously for 21 days,
which resulted in a rapid symptomatic and clinical response.